 International Prognostic Scoring System

The International Prognostic Scoring System (IPSS), published in 1997, is used by many doctors to help assess the severity of a patient's myelodysplastic syndrome (MDS).Based on the IPSS score, the patient's history, and his/her personal observations, the physician will design a treatment plan to address the MDS.